What are the characteristics of liver cirrhosis stage 4, also known as decompensated cirrhosis (Liver Cirrhosis Stage 4)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Decompensated cirrhosis, also known as liver cirrhosis stage 4, is characterized by the development of overt clinical signs such as ascites, bleeding, encephalopathy, and jaundice, and requires comprehensive management to improve quality of life and reduce morbidity and mortality. The characteristics of liver cirrhosis stage 4 include extensive fibrosis and architectural distortion of the liver, with a high risk of developing complications such as variceal hemorrhage, ascites, hepatic encephalopathy, and spontaneous bacterial peritonitis 1. The management of decompensated cirrhosis involves addressing the underlying cause of cirrhosis, such as abstinence from alcohol, antiviral therapy for hepatitis, or weight loss for fatty liver disease, and managing complications with medications such as non-selective beta-blockers, diuretics, and lactulose 1. Key aspects of management include:

  • Regular monitoring by a hepatologist every 3-6 months
  • Screening for complications including upper endoscopy, ultrasound with alpha-fetoprotein testing, and regular assessment for ascites, hepatic encephalopathy, and coagulopathy
  • Avoiding hepatotoxic medications, limiting sodium intake, and abstaining from alcohol
  • Evaluation for liver transplantation The pathophysiology of decompensated cirrhosis involves a complex interplay of haemodynamic disturbances, immune dysfunction, and multi-organ/system dysfunction, and current strategies for management rely on measures aimed at preventing or improving the outcome of each complication 1. Proper management of decompensated cirrhosis can slow progression and improve quality of life, and it is essential to prioritize the single most recent and highest quality study, which in this case is the 2024 AGA clinical practice update on the use of vasoactive drugs and intravenous albumin in cirrhosis 1.

From the Research

Characteristics of Liver Cirrhosis Stage 4

Liver cirrhosis stage 4, also known as decompensated cirrhosis, is characterized by:

  • Ascites, which is the accumulation of fluid in the peritoneal cavity 2
  • Spontaneous bacterial peritonitis, which is an infection of the fluid in the peritoneal cavity 2, 3
  • Hepatic encephalopathy, which is a condition characterized by cognitive disturbances, ranging from mild confusion to coma 2, 3
  • Variceal bleeding, which is bleeding from enlarged veins in the esophagus or stomach 2, 3
  • Portal hypertension, which is high blood pressure in the portal vein, the vein that carries blood from the intestines to the liver 4

Diagnosis and Evaluation

Diagnosis of liver cirrhosis stage 4 is typically made through a combination of:

  • Physical examination 5, 3
  • Laboratory tests, such as liver function tests and complete blood count 6, 5, 3
  • Imaging studies, such as ultrasonography and transient elastography 6, 3, 4
  • Liver biopsy, which is the gold standard for diagnosis and staging of cirrhosis 5, 3, 4

Management and Treatment

Management and treatment of liver cirrhosis stage 4 typically involve:

  • Directed counseling and lifestyle modifications 6, 3
  • Medications, such as nonselective beta blockers, diuretics, and lactulose 2, 3
  • Monitoring for complications, such as hepatocellular carcinoma and spontaneous bacterial peritonitis 2, 3
  • Evaluation for liver transplantation 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Liver Disease: Cirrhosis.

FP essentials, 2021

Research

Understanding the Complexities of Cirrhosis.

Clinical therapeutics, 2015

Research

Cirrhosis: Diagnosis and Management.

American family physician, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.